三维交互网络:线粒体-代谢-平衡驱动阿尔茨海默病的疾病
Tingting Liu1, Zongting Rong1, Jingwen Li1
1Institute for Brain Sciences Research, School of Life Sciences, Henan University, Kaifeng, Henan 475004, China.
Genes & diseases
|February 9, 2026
概括
阿尔茨海默病涉及线粒体,代谢和功能障碍的病理三位一体. 了解它们的相互作用是开发这种神经退行性疾病的多目标疗法的关键.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 病理学 病理学 病理学
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病.
- 阿尔茨海默病的发病与线粒体功能障碍,代谢失调和平衡不平衡有关.
- 这些因素形成了一个相互增强的网络,放大了AD病理.
研究的目的:
- 批判性地综合有关AD病理三位一体相互作用的证据.
- 为了剖析线粒体,代谢和功能障碍在体内如何相互作用.
- 评估临床前发现的临床可转化性,并提出治疗策略.
主要方法:
- 来自人类研究,动物模型和体外系统的证据综合.
- 对连接线粒体,代谢和路径的分子机制的分析.
- 评估临床试验数据并确定研究缺口.
主要成果:
- 线粒体损伤会损害ATP的产生,导致代谢重编程和破坏缓冲.
- 代谢和过载会通过ROS和mPTP开放加剧线粒体损伤.
- 粉样蛋白-β和病理学放大了这些三位一体功能障碍.
结论:
- 病理三位一体是阿尔茨海默氏症中一个中心的,自我放大机制.
- 针对这个三位一体提供了一个有前途的治疗途径.
- 生物标志物是必要的,以分层患者个性化,多目标疗法.
相关概念视频
Mitochondrial Membranes
11.7K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
11.7K
Electron Transport Chain: Complex I and II
11.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.9K
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35


